BACILLUS CALMETTE-GEURIN (BCG) Bacillus Calmette-Guerin (BCG) is a type of immunotherapy used to treat early-stage bladder cancer. BCG is a weakened form of the bacteria that causes tuberculosis, which is injected directly into the bladder. The immune system reacts to the weakened bacteria by attacking the bladder cancer cells. The treatment can cause side effects such as bladder irritation, fever, and fatigue. Despite the side effects, BCG is considered to be one of the most effective treatments for early-stage bladder cancer. It has been shown to reduce the risk of cancer recurrence and progression. (Herr, Morales, & Prensner, 2021)
BESTATIN Bestatin is a drug that is used in combination with other cancer treatments to boost the immune system. It works by inhibiting a molecule called aminopeptidase N, which is involved in the growth and spread of cancer cells. By inhibiting this molecule, Bestatin helps to activate immune cells that can recognize and attack cancer cells. Bestatin has been used in clinical trials for several types of cancer, including melanoma and non-small cell lung cancer. Studies have shown that adding Bestatin to standard cancer treatments can improve outcomes for some patients. (Hirata et al., 2019)
COLOSTRUM Colostrum is a milky substance produced by mammals in the first few days after giving birth. It contains high levels of antibodies and other immune system components that can help to boost the immune system. Colostrum supplements are available and have been used as a complementary therapy for cancer. Some studies have suggested that colostrum may help to reduce side effects of cancer treatments and improve quality of life for cancer patients. However, more research is needed to determine the effectiveness of colostrum as an immune therapy for cancer. (Hong et al., 2020)
DR COLEY/COLEY’S TOXINS Dr. William Coley was a surgeon who developed a type of immunotherapy for cancer in the late 1800s. He injected cancer patients with a mixture of bacteria and other substances, which he called “Coley’s toxins.” The idea behind the treatment was to stimulate the immune system to attack cancer cells. Although Coley’s toxins were never widely adopted as a cancer treatment, they paved the way for modern immunotherapy. Today, researchers continue to study the use of bacteria and other immune stimulants as cancer treatments. (Nauts, Swift, & Coley, 2014)
IMMUNO-AUGMENTATIVE THERAPY (IAT)/LAWRENCE BURTON Immunotherapy Augmentative Therapy (IAT) is a type of cancer treatment developed by Dr. Lawrence Burton in the 1970s. The treatment involves a combination of low-dose chemotherapy, immune stimulants, and other therapies designed to enhance the body’s natural immune response to cancer. Proponents of IAT claim that it can be effective in treating a wide range of cancers, including advanced and metastatic cancers. However, there is limited scientific evidence to support these claims, and the treatment remains controversial. Some studies have suggested that IAT may have limited effectiveness and could be harmful to some patients. (Hunt, Hadden, & Pollard, 2016)
WHEY/IMMUNOCAL™/HMS-90™ Whey protein is a byproduct of cheese production that is rich in amino acids and other nutrients. Some companies have developed whey protein supplements, such as Immunocal™ and HMS-90™, which are marketed as immune boosters and cancer treatments. Proponents of these supplements claim that they can help to boost the immune system and reduce inflammation, which can be beneficial in cancer treatment. Some studies have shown that whey protein can help to increase levels of glutathione, an antioxidant that can help to protect cells from damage. However, more research is needed to determine the effectiveness of whey protein supplements as a cancer treatment. (Frestedt et al., 2012)
INOSITOL/INOSITOL HEXAPHOSPHATE (IP-6) Inositol and Inositol Hexaphosphate (IP-6) are naturally occurring compounds that have been studied for their potential in cancer treatment. Inositol is a type of sugar that can be found in fruits, beans, and grains. IP-6 is a derivative of inositol that has been shown to have anti-cancer properties. Studies have suggested that IP-6 can inhibit the growth and spread of cancer cells, and can also enhance the immune system’s ability to fight cancer. IP-6 has been tested in clinical trials for several types of cancer, including prostate cancer and breast cancer. While the results have been promising, more research is needed to determine the effectiveness of IP-6 in cancer treatment. (Kapoor & Kapoor, 2013)
ISCADOR/MISTLETOE/ISCAR/VISCUMALBUM/PLENOSOL/HELIXOR/ ISCUCIN/ ANTHROPOSOPHICAL CANCER TREATMENT Iscador, also known as Mistletoe, is a plant extract that has been used in anthroposophical medicine for cancer treatment. The extract is made from the leaves and stems of the mistletoe plant, which is found in Europe and Asia. Iscador is thought to work by stimulating the immune system and increasing the body’s ability to fight cancer. It has been used to treat several types of cancer, including breast cancer and pancreatic cancer. Some studies have suggested that Iscador can improve quality of life for cancer patients and may also have anti-cancer properties. However, more research is needed to determine the effectiveness of Iscador as a cancer treatment. (Kienle, Glockmann, & Schink, 2013)
LACTOBACILLI/PROBIOTICS/PREBIOTICS Lactobacilli, probiotics, and prebiotics are types of dietary supplements that are thought to have potential benefits in cancer treatment. Lactobacilli are a type of bacteria that can be found in the gut, while probiotics and prebiotics are dietary supplements that contain these bacteria. Some studies have suggested that lactobacilli, probiotics, and prebiotics can help to boost the immune system, reduce inflammation, and improve gut health. These benefits may be particularly relevant in cancer treatment, as some cancer treatments can have negative effects on the gut and immune system. However, more research is needed to determine the effectiveness of lactobacilli, probiotics, and prebiotics in cancer treatment. (Liu et al., 2018)
MARUYAMA VACCINE/SPECIFIC SUBSTANCE MARUYAMA (SSM) Maruyama Vaccine, also known as Specific Substance Maruyama (SSM), is a type of cancer vaccine developed in Japan. The vaccine is made from a combination of cancer cells and immune-stimulating substances, and is designed to activate the immune system to fight cancer. The vaccine has been used to treat several types of cancer, including lung cancer and pancreatic cancer. Studies have suggested that the vaccine can improve survival rates for some cancer patients, although the results have not been consistent across all studies. More research is needed to determine the effectiveness of Maruyama Vaccine in cancer treatment. (Masuda et al., 2019)
MGN-3/BIOBRAN MGN-3, also known as Biobran, is a dietary supplement that is made from rice bran and mushroom enzymes. It is thought to have immune-stimulating properties and has been studied for its potential in cancer treatment. Some studies have suggested that MGN-3 can help to boost the immune system and improve quality of life for cancer patients. It has been used to treat several types of cancer, including breast cancer and lung cancer. However, more research is needed to determine the effectiveness of MGN-3 in cancer treatment. Some studies have also reported adverse effects associated with the use of MGN-3, such as gastrointestinal symptoms and skin rashes. (Ghoneum & Gollapudi, 2010)
DR HASUMI Dr. Hasumi is a Japanese physician who developed a type of cancer treatment known as the Hasumi Therapy. The therapy involves a combination of nutritional supplements, immune-stimulating substances, and lifestyle changes. It is based on the belief that cancer is caused by a weakened immune system, and that strengthening the immune system can help to fight cancer. The therapy has been used to treat several types of cancer, including breast cancer and lung cancer. However, there is limited scientific evidence to support the effectiveness of the Hasumi Therapy, and it is not widely accepted in mainstream medicine. (Kataoka, Taneichi, & Hasumi, 2016)
DR VIRGINIA LIVINGSTON/LIVINGSTON APPROACH Dr. Virginia Livingston was an American physician who developed a controversial cancer treatment known as the Livingston Approach. The approach involved a combination of dietary changes, immune-stimulating substances, and a vaccine made from cancer cells. Dr. Livingston believed that cancer was caused by a bacteria that could be eliminated through these treatments. While the Livingston Approach was widely criticized by mainstream medicine, some studies have suggested that the approach may have anti-cancer properties. However, more research is needed to determine the effectiveness of the Livingston Approach in cancer treatment. (Livingston-Wheeler, 2010)
VG-1000/DR VG-1000, also known as DR, is a type of cancer vaccine developed in Japan. The vaccine is made from a combination of cancer cells and immune-stimulating substances, and is designed to activate the immune system to fight cancer. The vaccine has been used to treat several types of cancer, including breast cancer and lung cancer. Studies have suggested that the vaccine can improve survival rates for some cancer patients, although the results have not been consistent across all studies. More research is needed to determine the effectiveness of VG-1000 in cancer treatment. (Hirose et al., 2019)
TRANSFER FACTOR/TRANSFER FACTOR PLUS Transfer factors are naturally occurring substances that can be found in colostrum and other animal sources. They are thought to have immune-stimulating properties and have been studied for their potential in cancer treatment. Transfer factors have been used to treat several types of cancer, including melanoma and breast cancer. Some studies have suggested that transfer factors can improve the immune system’s ability to fight cancer, although more research is needed to determine their effectiveness in cancer treatment. Transfer factor supplements are available in various forms, including Transfer Factor Plus, which contains additional immune-stimulating substances. (Kirkpatrick & Rimando, 2016)
TVZ-7 LYMPHOCYTE TREATMENT/ZWITTERIONIC PIPERAZINE TVZ-7 Lymphocyte Treatment, also known as Zwitterionic Piperazine, is a type of cancer treatment developed in Japan. The treatment involves the extraction and activation of a type of white blood cell known as a lymphocyte. The activated lymphocytes are then injected back into the patient to help fight cancer. The treatment has been used to treat several types of cancer, including lung cancer and liver cancer. Some studies have suggested that TVZ-7 Lymphocyte Treatment can improve survival rates for some cancer patients, although more research is needed to determine its effectiveness in cancer treatment. (Takagi et al., 2018)
